DHPS and pneumocystosis: While studies have demonstrated an association between the use of sulfa drugs for PCP prophylaxis and DHPS mutations, whether these mutations confer resistance to sulfamethoxazole, for PCP treatment is unclear as published studies provide conflicting results (summarized in Huang et al., 2004; Alvarez-Martínez et al., 2010).